Treatment of Basal Cell Carcinomas With Methyl Aminolevulinate and Daylight

Bispebjerg Hospital

Status and phase: Unknown; Phase 2

Conditions: Photodynamic Therapy; Basal Cell Carcinomas

Treatments: Procedure: Daylight mediated photodynamic therapy

Study type: Interventional

Funder types: Other

Identifiers

NCT01349361

2010-024517-31

Details and patient eligibility

About

Photodynamic Therapy (PDT) is an effective treatment of basal cell carcinomas (BCC) however the inconvenience of clinic attendance and discomfort during therapy are significant drawbacks. The objective of this study is to evaluate the effect of daylight-mediated PDT of BCC.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• superficial BCC

Exclusion criteria

• Immunosuppression

Trial design

0 participants in 1 patient group

Daylight-PDT

Experimental group

Treatment:

Procedure: Daylight mediated photodynamic therapy